Dengue Tetravalent Vaccine Containing a Common 30 Nucleotide Deletion in The 3'-UTR of Dengue Types 1,2,3, And 4, or Antigenic Chimeric Dengue Viruses 1,2,3, And 4
European Patent
10177740.7
Filed on 2003-04-25
10177740.7
Filed on 2003-04-25
Dengue Tetravalent Vaccine Containing a Common 30 Nucleotide Deletion in The 3-UTR of Dengue Types 1,2,3, And 4, or Antigenic Chimeric Dengue Viruses 1,2,3, And 4
European Patent
10177735.7
Filed on 2003-04-25
10177735.7
Filed on 2003-04-25
Recombinant Modified Vaccinia Virus Ankara (MVA) Vaccinia Virus Containing Restructures Insertion Sites
Patent Cooperation Treaty
PCT/US2010/052929
Filed on 2010-10-15
PCT/US2010/052929
Filed on 2010-10-15
Mechanisms For Protection Against Pandemic Strains Of Influenza
Patent Cooperation Treaty
PCT/US2010/051512
Filed on 2010-10-05
PCT/US2010/051512
Filed on 2010-10-05
Specific Labeling Reagents For The Detection Of Mycobacterial Infections
Patent Cooperation Treaty
PCT/GB2010/051519
Filed on 2010-09-10
PCT/GB2010/051519
Filed on 2010-09-10
Induction Of Profliferation, Effector Molecule Expression, And Cytolytic Capacity Of HIV -Specific CDS + T Cells
US Application 12/934,522
Filed on 2010-09-24
Filed on 2010-09-24
Induction Of Profliferation, Effector Molecule Expression And Cytolytic Capacity Of HIV -Specific CDS+ T Cells
European Patent
09762793.9
Filed on 2009-03-25
09762793.9
Filed on 2009-03-25
Aerosolized Genetic Vaccines And Methods of Use
US Application 12/887,286
Filed on 2010-09-21
Filed on 2010-09-21